| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |